Epitope Inc said board director authorized three-for-one common stock split shareholder approval expected next two week .
The company announced two-for-one split last week , said board reconvened agreed change three-for-one split .
Epitope involved production monoclonal antibody diagnostic therapeutic use AIDS immunological disease .
Reuter & # 3 ; 